Destiny Wealth Partners, LLC Biogen Inc. Transaction History

Destiny Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$256.56 - $292.34 $32,583 - $37,127	-127 Reduced 12.5%	889 $247,000
Q4 2022 Jan 26, 2023	BUY	$252.44 - $306.72 $245,371 - $298,131	972 Added 2209.09%	1,016 $0
Q4 2021 Jan 20, 2022	SELL	$223.92 - $287.77 $8,956 - $11,510	-40 Reduced 47.62%	44 $11,000
Q3 2021 Oct 28, 2021	BUY	$282.99 - $369.05 $23,771 - $31,000	84 New	84 $24,000
Q2 2021 Jul 27, 2021	SELL	$259.0 - $414.71 $21,756 - $34,835	-84 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$236.26 - $355.63 $19,845 - $29,872	84 New	84 $21,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.